ADHD is likely influenced by both genetics and the environment, starting before birth. Research shows this, however the biological mechanisms of ADHD have been puzzling scientists for years. Research involving ADHD and epigenetics — a process that regulates how genes respond to environmental factors like diet, pollution, or stress — is still in its early stages. We do know that these processes are essential for healthy development, and that disruptions are thought to contribute to various health issues, including neurodevelopmental and psychiatric disorders.

Epigenetic research offers valuable insights into the development of ADHD, which could one day pave the way for improvements in early detection, treatment, and potentially even prevention. Although clinical applications remain in the distant future, these emerging clues hold promise for addressing ADHD more effectively in the long run.

In this webinar, you will:

• Learn how epigenetic processes regulate the interaction between genes and the environment, shaping our development and overall health
• Understand the effects of maternal health conditions and risk factors around the prenatal and perinatal periods
• Discover how epigenetic research is already making an impact in various health fields, improving screening, early disease detection (e.g., cancer), and guiding treatment decisions and drug-effectiveness assessments
• Hear about lessons learned from new epigenetic research on ADHD and what the future may hold in terms of potential clinical applications